Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evoke Pharma
(NQ:
EVOK
)
4.410
-0.020 (-0.45%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evoke Pharma
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 01, 2023
Via
Benzinga
Evoke Pharma's Return On Capital Employed Insights
March 22, 2023
Via
Benzinga
Earnings Scheduled For March 21, 2023
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
Evoke Pharma Earnings Preview
March 20, 2023
Via
Benzinga
Evoke Pharma's Return On Capital Employed Insights
December 14, 2022
Via
Benzinga
Evoke Pharma: Q2 Earnings Insights
August 10, 2022
Evoke Pharma (NASDAQ:EVOK) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 30, 2023
Via
Benzinga
Earnings Preview: Evoke Pharma
November 08, 2022
Evoke Pharma (NASDAQ:EVOK) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Evoke Pharma...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 18, 2022
Gainers Akouos (NASDAQ:AKUS) shares moved upwards by 86.2% to $13.05 during Tuesday's pre-market session. The company's market cap stands at $481.5 million.
Via
Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
June 27, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...
Via
Benzinga
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
June 24, 2022
Gainers USA Truck, Inc. (NASDAQ: USAK) shares jumped 111% to $30.76. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Fed Boosts Interest Rates by 0.75%
June 15, 2022
U.S. stocks traded higher toward the end of trading, after the Federal Reserve raised interest rates by 0.75%.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 15, 2022
Via
Benzinga
71 Biggest Movers From Yesterday
June 16, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 225% to close at $4.68 on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration...
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises 200 Points; 180 Life Sciences Shares Plummet
June 15, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Wednesday.
Via
Benzinga
55 Stocks Moving In Wednesday's Mid-Day Session
June 15, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares surged 92.4% to $2.77 after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity...
Via
Benzinga
Why One Analyst Thinks Robinhood (HOOD) Stock Will Plunge to $5
June 15, 2022
Robinhood (HOOD) stock could be set for a major fall if one analyst's prediction for the stock and crypto trading app turns out true.
Via
InvestorPlace
Evoke Pharma (EVOK) Stock Soars 50% on Medicaid Drug Approval
June 15, 2022
Evoke Pharma (EVOK) stock is rocketing higher on Wednesday after the company got Medicaid approval for its GIMOTI nasal spray.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Higher; US Retail Sales Drop In May
June 15, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5%
May 23, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday.
Via
Benzinga
Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge
May 23, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday.
Via
Benzinga
30 Stocks Moving In Monday's Mid-Day Session
May 23, 2022
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare
May 23, 2022
U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 17, 2022
Good morning, investor! It's time for another busy day of trading as we dive into the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
24 Stocks Moving in Tuesday's Pre-Market Session
May 17, 2022
Gainers Bird Global, Inc. (NASDAQ: BRDS) rose 26.3% to $1.24 in pre-market trading after the company posted strong Q1 sales.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.